Alpha Tau Medical Ltd

자세한 내용은 Alpha Tau Medical Ltd 회사

Alpha Tau Medical Ltd is an Israel-based medical technology company that focuses on research, development and commercialization of Alpha DaRT Diffusing Alpha-emitters Radiation Therapy (Alpha DaRT) for the treatment of solid cancer. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The Company has one subsidiary Healthcare Capital Corp.

회사 정보

종목 코드 DRTS

회사 이름Alpha Tau Medical Ltd

상장일Mar 08, 2022

CEOMr. Uzi Sofer

직원 수125

유형Ordinary Share

회계 연도 종료Mar 08

주소Kiryat Hamada 5

도시JERUSALEM

증권 거래소NASDAQ Capital Market Consolidated

국가Israel

우편 번호9777605

전화97235774115

웹사이트https://www.alphatau.com/

종목 코드 DRTS

상장일Mar 08, 2022

CEOMr. Uzi Sofer

회사 임원

이름

이름/직위

직위

주식 보유

변동

Mr. Uzi Sofer

Chairman of the Board, Chief Executive Officer

11.52M

--

Mr. Michael Avruch

Independent Director

1.55M

+0.17%

Prof. Yona Keisari

Chief Scientific Officer

504.27K

+0.16%

Mr. Amnon Gat

Chief Operations Officer

68.47K

--

Mr. Raphi Levy

Chief Financial Officer

--

Prof. Itzhak Kelson

Chief Physics Officer

--

Dr. Robert Den, M.D.

Chief Medical Officer

--

Mr. Gary Leibler

Independent Director

--

Mr. Alan Adler

Independent Director

--

Dr. S. Morry Blumenfeld, Ph.D.

Independent Director

--

이름

이름/직위

직위

주식 보유

변동

Mr. Uzi Sofer

Chairman of the Board, Chief Executive Officer

11.52M

--

Mr. Michael Avruch

Independent Director

1.55M

+0.17%

Prof. Yona Keisari

Chief Scientific Officer

504.27K

+0.16%

Mr. Amnon Gat

Chief Operations Officer

68.47K

--

Mr. Raphi Levy

Chief Financial Officer

--

Prof. Itzhak Kelson

Chief Physics Officer

--

수익 분석

데이터 없음

데이터 없음

사업별

지역별

데이터 없음

주식 보유 통계

마지막 업데이트: Fri, May 16

주주

주주 유형

주주

비율

Oramed Pharmaceuticals Inc

16.66%

Sofer (Uzi)

13.60%

Avruch (Michael)

1.83%

Keisari (Yona)

0.60%

HoyleCohen, LLC

0.32%

Other

67.00%

주주

비율

Oramed Pharmaceuticals Inc

16.66%

Sofer (Uzi)

13.60%

Avruch (Michael)

1.83%

Keisari (Yona)

0.60%

HoyleCohen, LLC

0.32%

Other

67.00%

주주 유형

주주

비율

Corporation

16.66%

Individual Investor

16.26%

Investment Advisor

0.96%

Investment Advisor/Hedge Fund

0.68%

Hedge Fund

0.07%

Bank and Trust

0.04%

Venture Capital

0.03%

Other

65.30%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

54

29.39M

34.70%

+13.97M

2025Q1

56

19.44M

23.97%

-491.93K

2024Q4

55

19.31M

27.55%

-2.82M

2024Q3

59

19.28M

27.51%

-4.37M

2024Q2

62

19.31M

27.55%

-4.87M

2024Q1

65

19.84M

28.32%

-4.33M

2023Q4

137

22.06M

31.83%

-24.51M

2023Q3

140

32.52M

46.94%

-14.56M

2023Q2

146

33.02M

48.83%

-14.67M

2023Q1

145

32.68M

48.37%

-16.77M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

Oramed Pharmaceuticals Inc

14.11M

16.66%

+14.11M

--

Apr 24, 2025

Sofer (Uzi)

11.52M

13.6%

--

Mar 01, 2025

Avruch (Michael)

1.55M

1.83%

+2.71K

+0.17%

Mar 01, 2025

Keisari (Yona)

504.27K

0.6%

+781.00

+0.16%

Mar 01, 2025

HoyleCohen, LLC

269.09K

0.32%

--

Jun 30, 2024

Hightower Advisors, LLC

230.70K

0.27%

--

Mar 31, 2025

Kovitz Investment Group Partners, LLC

226.32K

0.27%

+194.06K

+601.44%

Mar 31, 2025

Levin Capital Strategies, L.P.

222.51K

0.26%

-92.00K

-29.25%

Mar 31, 2025

Milch (David Mark)

88.74K

0.1%

-2.00K

-2.20%

Mar 01, 2025

Gat (Amnon)

68.47K

0.08%

--

Mar 01, 2025

3.010USD

Alpha Tau Medical Ltd

3.010

개요

회사

금융